Ident. | Authors (with country if any) | Title |
---|
000568 |
Constant V. M. Verschuur [Pays-Bas] ; S. R. Suwijn [Pays-Bas] ; B. Post [Pays-Bas] ; M. Dijkgraaf [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; T. Van Laar [Pays-Bas] ; G. Tissingh [Pays-Bas] ; G. Deuschl [Allemagne] ; A. E. Lang [Canada] ; R. J. De Haan [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] | Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study |
001396 |
R. A. Walsh [Canada] ; A. E. Lang [Canada] | Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine |
001519 |
R. B. Postuma [Canada] ; A. E. Lang [Canada] ; J. F. Gagnon [Canada] ; A. Pelletier [Canada] ; J. Y. Montplaisir [Canada] | How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder |
001549 |
Tiago A. Mestre [Canada, Portugal] ; A. E. Lang [Canada] ; Joaquim J. Ferreira [Portugal] ; Vânia Almeida [Portugal] ; Mamede De Carvalho [Portugal] ; Janis Miyasaki [Canada] ; Robert Chen [Canada] ; Susan Fox [Canada] | Associated movement disorders in orthostatic tremor |
001925 |
C. Marras [Canada] ; B. Schuele [États-Unis] ; R. P. Munhoz [Brésil] ; E. Rogaeva [Canada] ; J. W. Langston [États-Unis] ; M. Kasten [Allemagne] ; C. Meaney [Canada] ; C. Klein [Allemagne] ; P. M. Wadia [Canada] ; S.-Y. Lim [Canada] ; R. S.-I. Chuang [Canada] ; C. Zadikof [Canada] ; T. Steeves [Canada] ; K. M. Prakash [Canada] ; R. M. A. De Bie [Canada] ; G. Adeli [Canada] ; T. Thomsen [Canada] ; K. K. Johansen [Norvège] ; H. A. Teive [Brésil] ; A. Asante [Canada] ; W. Reginold [Canada] ; A. E. Lang [Canada] | Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers |
001D22 |
T. Van Eimeren [Canada] ; G. Pellecchia [Canada] ; R. Cilia [Canada] ; B. Ballanger [Canada] ; T. D. L. Steeves [Canada] ; S. Houle [Canada] ; J. M. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; A. P. Strafella [Canada] | Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD |
001F21 |
T. D. L. Steeves [Canada] ; J. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; G. Pellecchia [Canada] ; T. Van Eimeren [Canada] ; P. Rusjan [Canada] ; S. Houle [Canada] ; A. P. Strafella [Canada] | Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study |
001F50 |
A. C. Ludolph [Allemagne] ; J. Kassubek [Allemagne] ; B. G. Landwehrmeyer [Allemagne] ; E. Mandelkow [Allemagne] ; E. Mandelkow [Allemagne] ; D. J. Burn [Royaume-Uni] ; D. Caparros-Lefebvre [France] ; K. A. Frey [États-Unis] ; J. G. De Yebenes [Espagne] ; T. Gasser [Allemagne] ; P. Heutink [Pays-Bas] ; G. Höglinger [Allemagne] ; Z. Jamrozik [Pologne] ; K. A. Jellinger [Autriche] ; A. Kazantsev [États-Unis] ; H. Kretzschmar [Allemagne] ; A. E. Lang [Canada] ; I. Litvan [États-Unis] ; J. J. Lucas [Espagne] ; P. L. Mcgeer [Canada] ; S. Melquist [États-Unis] ; W. Oertel [Allemagne] ; M. Otto [Allemagne] ; D. Paviour [Royaume-Uni] ; T. Reum [Allemagne] ; A. Saint-Raymond [Royaume-Uni] ; J. C. Steele ; M. Tolnay [Suisse] ; H. Tumani [Allemagne] ; J. C. Van Swieten [Pays-Bas] ; M. T. Vanier [France] ; J. Vonsattel [États-Unis] ; S. Wagner [Allemagne] ; Z. K. Wszolek [États-Unis] | Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options |
002094 |
J. Chu [Canada] ; A. Wagle-Shukla [Canada] ; C. Gunraj [Canada] ; A. E. Lang [Canada] ; R. Chen [Canada] | Impaired presynaptic inhibition in the motor cortex in Parkinson disease |
002414 |
E. Moro [Canada] ; J. Volkmann [Allemagne] ; I. R. Konig [Allemagne] ; S. Winkler [Allemagne] ; A. Hiller [Allemagne] ; S. Hassin-Baer [Israël] ; J. Herzog [Allemagne] ; A. Schnitzler [Allemagne] ; K. Lohmann [Allemagne] ; M. O. Pinsker [Allemagne] ; J. Voges [Allemagne] ; A. Djarmatic [Allemagne] ; P. Seibler [Allemagne] ; A. M. Lozano [Canada] ; E. Rogaeva [Canada] ; A. E. Lang [Canada] ; G. Deuschl [Allemagne] ; C. Klein [Canada, Allemagne] | Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism |
002640 |
A. Sailer [Canada, Suède] ; D. I. Cunic [Canada] ; G. O. Paradiso [Canada] ; C. A. Gunraj [Canada] ; A. Wagle-Shukla [Canada] ; E. Moro [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Chen [Canada] | Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease |
002691 |
R. M. A. De Bie [Canada, Pays-Bas] ; J. Miyasaki [Canada] ; A. E. Lang [Canada] ; S. H. Fox [Canada] | Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease |
002890 |
R. B. Postuma [Canada] ; A. J. Espay [Canada] ; C. Zadikoff [Canada] ; O. Suchowersky [Canada] ; W. R. W. Martin [Canada] ; A.-L. Lafontaine [Canada] ; R. Ranawaya [Canada] ; R. Camicioli [Canada] ; A. E. Lang [Canada] | Vitamins and entacapone in levodopa-induced hyperhomocysteinemia : A randomized controlled study |
002907 |
V. Voon [États-Unis, Canada] ; K. Hassan [Canada] ; M. Zurowski [Canada] ; S. Duff-Canning [Canada] ; M. De Souza [Canada] ; S. Fox [Canada] ; A. E. Lang [Canada] ; J. Miyasaki [Canada] | Prospective prevalence of pathologic gambling and medication association in Parkinson disease |
002908 |
V. Voon [États-Unis, Canada] ; K. Hassan [Canada] ; M. Zurowski [Canada] ; M. De Souza [Canada] ; T. Thomsen [Canada] ; S. Fox [Canada] ; A. E. Lang [Canada] ; J. Miyasaki [Canada] | Prevalence of repetitive and reward-seeking behaviors in Parkinson disease |
002B01 |
C. Marras [Canada] ; M. P. Mcdermott [États-Unis] ; P. A. Rochon [Canada] ; C. M. Tanner [États-Unis] ; G. Naglie [Canada] ; A. Rudolph [États-Unis] ; A. E. Lang [Canada] | Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohort |
002B15 |
S. F. Farmer [Royaume-Uni] ; A. J. Espay [Canada] ; J.-Y. Li [Canada] ; L. Johnston [Canada] ; R. Chen [Canada] ; A. E. Lang [Canada] | Mirror movements in parkinsonism : evaluation of a new clinical sign. Commentary |
002B19 |
C. Paisan-Ruiz [États-Unis, Espagne] ; A. E. Lang [Canada] ; T. Kawarai [Canada] ; C. Sato [Canada] ; S. Salehi-Rad [Canada] ; G. K. Fisman [Canada] ; T. Al-Khairallah [Canada] ; P. St George-Hyslop [Canada] ; A. Singleton [États-Unis] ; E. Rogaeva [Canada] | LRRK2 gene in parkinson disease : Mutation analysis and case control association study |
002B46 |
Hans-Joachim Freund [Allemagne] ; M. C. Rodriguez-Oroz [Espagne] ; J. A. Obeso [Espagne] ; A. E. Lang [Canada] ; J.-L. Houeto [France] ; P. Pollak [France] ; S. Rehncrona [France] ; J. Kulisevsky [Espagne] ; A. Albanese [Italie] ; J. Volkmann [Allemagne] ; M. I. Hariz [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; J. D. Speelman [Pays-Bas] ; J. Guridi [Espagne] ; I. Zamarbide [Espagne] ; A. Gironell [Espagne] ; J. Molet [Espagne] ; B. Pascual-Sedano [Espagne] ; B. Pidoux [France] ; A. M. Bonnet [France] ; Yves Agid [France] ; J. Xie [France] ; A.-L. Benabid [France] ; A. M. Lozano [Canada] ; J. Saint-Cyr [Canada] ; L. Romito [Italie] ; M. F. Contarino [Italie] ; M. Scerrati [Italie] ; V. Fraix [France] ; N. Van Blercom [France] | Bilateral deep brain stimulation in Parkinson's disease : a multicentre study with 4 years follow-up. Commentary |
002D32 |
R. P. Munhoz [Canada] ; J.-Y. Li [Canada] ; M. Kurtinecz [Canada] ; P. Piboolnurak [États-Unis] ; A. Constantino [États-Unis] ; S. Fahn [États-Unis] ; A. E. Lang [Canada] | Evaluation of the pull test technique in assessing postural instability in Parkinson's disease |
002D34 |
S. Kedia [États-Unis] ; E. Moro [Canada] ; M. Tagliati [États-Unis] ; A. E. Lang [Canada] ; R. Kumar [États-Unis] | Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease |
002D42 |
K. Hedrich [Allemagne] ; A. Djarmati [Allemagne, Serbie] ; N. Sch Fer [Allemagne] ; R. Hering [Allemagne] ; C. Wellenbrock [Allemagne] ; P. H. Weiss [Allemagne] ; R. Hilker [Allemagne] ; P. Vieregge [Allemagne] ; L. J. Ozelius [États-Unis] ; P. Heutink [Pays-Bas] ; V. Bonifati [Pays-Bas, Italie] ; E. Schwinger [Allemagne] ; A. E. Lang [Canada] ; J. Noth [Allemagne] ; S. B. Bressman [États-Unis] ; P. P. Pramstaller [Italie] ; O. Riess [Allemagne] ; C. Klein [Allemagne] | DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease |
002F07 |
J. G. Nutt [États-Unis] ; K. J. Burchiel [États-Unis] ; C. L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; A. E. Lang [Canada] ; E. R. Jr Laws [États-Unis] ; A. M. Lozano [Canada] ; R. D. Penn [États-Unis] ; R. K. Jr Simpson [États-Unis] ; M. Stacy [États-Unis] ; G. F. Wooten [États-Unis] | Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD |
002F29 |
G. Paradiso [Canada] ; J. A. Saint-Cyr [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Chen [Canada] | Involvement of the human subthalamic nucleus in movement preparation |
003055 |
R. Levy [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | Simultaneous repetitive movements following pallidotomy or subthalamic deep brain stimulation in patients with Parkinson's disease |
003087 |
D. Cunic [Canada] ; L. Roshan [Canada] ; F. I. Khan [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Chen [Canada] | Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease |
003198 |
M. Fukuda ; M. J. Mentis ; Y. Ma ; V. Dhawan ; A. Antonini ; A. E. Lang [Canada] ; A. M. Lozano [Canada] ; J. Hammerstad ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis] ; J. R. Moeller ; D. Eidelberg | Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease |
003467 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Tre Panier [Canada] ; Rajeev Kumar [États-Unis] ; Andres M. Lozano ; A. E. Lang | Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease |
003548 |
R. Kumar [Canada] ; A. E. Lang [Canada] ; M. C. Rodriguez-Oroz [Espagne] ; A. M. Lozano [Canada] ; P. Limousin [France] ; P. Pollak [France] ; A. L. Benabid [France] ; J. Guridi [Espagne] ; E. Ramos [Espagne] ; C. Van Der Linden [Belgique] ; A. Vandewalle [Belgique] ; J. Caemaert [Belgique] ; E. Lannoo [Belgique] ; D. Van Den Abbeele [Belgique] ; G. Vingerhoets [Belgique] ; M. Wolters [Belgique] ; J. A. Obeso [Espagne] | eep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease |
003558 |
A. E. Lang [Canada] ; LANGSTON ; RASCOL ; BROTCHIE ; BENABID ; MELAMED ; BONUCELLI ; OLANOW ; OBESO ; GIMENEZ-ROLDAN ; RAJPUT ; FAHN ; NUTT ; BROOKS ; CHASE | Surgery for levodopa-induced dyskinesias. Discussion |
003559 |
A. E. Lang [Canada] | Surgery for Parkinson disease : A critical evaluation of the state of the art |
003572 |
L. L. Trepanier [Canada] ; R. Kumar [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] ; J. A. Saint-Cyr [Canada] | Neuropsychological outcome of GPI pallidotomy and GPI or STN deep brain stimulation in Parkinson's disease |
003575 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Levy [Canada] ; W. Hutchison [Canada] ; J. Dostrovsky [Canada] | Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine |
003580 |
J. Fine [Canada] ; J. Duff [Canada] ; R. Chen [Canada] ; W. Hutchison [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease |
003599 |
O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada] | A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa |
003790 |
R. E. Gross [Canada] ; W. J. Lombardi ; W. D. Hutchison ; S. Narula ; J. A. Saint-Cyr ; J. O. Dostrovsky ; R. R. Tasker ; A. E. Lang ; A. M. Lozano | Variability in lesion location after microelectrode-guided pallidotomy for Parkinson's disease : anatomical, physiological, and technical factors that determine lesion distribution |
003793 |
D. A. Grimes [Canada] ; A. E. Lang | Treatment of early Parkinson's disease |
003800 |
M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada] | SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD |
003806 |
A. E. Lang [Canada] ; J. Duff [Canada] ; J. A. Saint-Cyr [Canada] ; L. Trepanier [Canada] ; R. E. Gross [Canada] ; W. Lombardi [Canada] ; E. Montgomery [États-Unis] ; W. Hutchinson [Canada] ; A. M. Lozano [Canada] | Posteroventral medial pallidotomy in Parkinson's disease |
003813 |
P. Ashby [Canada] ; Y. J. Kim [Canada] ; R. Kumar [Canada] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] | Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus |
003822 |
M. Ichise [Canada] ; Y. J. Kim ; S. S. Erami ; J. R. Ballinger ; D. Vines ; F. Tanaka ; A. E. Lang | Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data |
003834 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Sime [Canada] ; E. Halket [Canada] ; A. E. Lang [Canada] | Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation |
003835 |
I. Litvan [États-Unis] ; D. A. Grimes [Canada] ; A. E. Lang [Canada] ; Joseph Jankovic [États-Unis] ; A. Mckee [États-Unis] ; M. Verny [France] ; K. Jellinger [Autriche] ; K. R. Chaudhuri [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] | Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration |
003960 |
H. A Hutchison [Canada] ; R. J. Allan [Canada] ; H. Opitz [Allemagne] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. E. Lang ; A. M. Lozano | Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease |
003A21 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] | Parkinson's disease : Second of two parts |
003A22 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] | Pallidotomy for tremor |
003A23 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada] | Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease |
003A24 |
N. Galvez-Jimenez [Canada] ; A. Lozano [Canada] ; R. Tasker [Canada] ; J. Duff [Canada] ; W. Hutchison [Canada] ; A. E. Lang [Canada] | Pallidal stimulation in Parkinson's disease patients with a prior unilateral pallidotomy |
003A25 |
L. L. Trepanier [Canada] ; J. A. Saint-Cyr [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease |
003A26 |
W. D. Hutchison [Canada] ; R. J. Allan [Canada] ; H. Opitz [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] | Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease |
003A29 |
A. M. Lozano [Canada] ; W. D. Hutchison [Canada] ; R. R. Tasker [Canada] ; A. E. Lang [Canada] ; F. Junn [Canada] ; J. O. Dostrovsky [Canada] | Microelectrode recordings define the ventral posteromedial pallidotomy target |
003A36 |
P. Ashby [Canada] ; A. Strafella [Canada] ; J. O. Dostrovsky [Canada] ; A. Lozano [Canada] ; A. E. Lang [Canada] | Immediate motor effects of stimulation through electrodes implanted in the human globus pallidus |
003A46 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; Y. J. Kim [Canada] ; W. D. Hutchison [Canada] ; E. Sime [Canada] ; E. Halket [Canada] ; A. E. Lang [Canada] | Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson disease |
003B59 |
A. Strafella [Canada] ; A. Ashby [Canada] ; A. E. Lang [Canada] | Reflex myoclonus in cortical‐basal ganglionic degeneration involves a transcortical pathway |
003B92 |
Simon Hutchison [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Effects of apomorphine on globus pallidus neurons in parkinsonian patients |
003C41 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; J. Duff [Canada] ; R. Tasker [Canada] ; W. Hutchinson [Canada] | Posteroventral medial pallidotomy in advanced Parkinson's disease |
003C43 |
A. Strafella [Canada] ; P. Ashby ; A. Lozano ; A. E. Lang | Pallidotomy increases cortical inhibition in Parkinson's disease |
003C44 |
R. R. Tasker [Canada] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] | Pallidal and thalamic surgery for Parkinson's disease |
003C48 |
K. Markopoulou [États-Unis] ; K. W. Larsen [États-Unis] ; E. K. Wszolek [États-Unis] ; M. A. Denson [États-Unis] ; A. E. Lang [Canada] ; R. F. Pfeiffer [États-Unis] ; Z. K. Wszolek [États-Unis] | Olfactory dysfunction in familial parkinsonism |
003C51 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] ; J. O. Dostrovsky [Canada] | Microelectrode recording-guided posteroventral pallidotomy in patients with Parkinson's disease |
003C52 |
A. E. Lang [Canada] ; A. Lozano [Canada] ; J. Duff [Canada] ; R. Tasker [Canada] ; J. Miyasaki ; N. Galvez-Jimenez ; W. Hutchison ; J. Dostrovsky | Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration |
003C56 |
W. D. Hutchison [Canada] ; A. M. Lozano [Canada] ; R. R. Tasker [Canada] ; A. E. Lang [Canada] ; J. O. Dostrovsky [Canada] | Identification and characterization of neurons with tremor-frequency activity in human globus pallidus |
003C62 |
W. D. Hutchison [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Effects of apomorphine on globus pallidus neurons in parkinsonian patients |
003C69 |
R. Kumar [Canada] ; A. E. Lang [Canada] | Coexistence of tics and parkinsonism : Evidence for non-dopaminergic mechanisms in tic pathogenesis |
003D94 |
C. Bergeron [Canada] ; M. S. Pollanen ; L. Weyer ; S. E. Black [Canada] ; A. E. Lang | Unusual clinical presentations of cortical‐basal ganglionic degeneration |
003E88 |
P. Sandor [Canada] ; A. E. Lang [Canada] ; S. Singal [Canada] ; C. Augus [Canada] | Remoxipride in the treatment of levodopa-induced psychosis |
003E89 |
N. Galvez-Jimenez [Canada] ; A. E. Lang [Canada] | Perioperative problems in Parkinson's disease and their management : Apomorphine with rectal domperidone |
003E93 |
C. L. Barclay [Canada] ; J. Duff ; P. Sandor ; A. E. Lang | Limited usefulness of electroconvulsive therapy in progressive supranuclear palsy |
003E94 |
SANJAY KALRA [Canada] ; C. Bergeron [Canada] ; A. E. Lang [Canada] | Lewy body disease and dementia : A review |
003F72 |
Y. Takiyama [Japon] ; S. Igasrashi [Japon] ; E. A. Rogaeva ; K. Endo [Japon] ; E. I. Rogaev ; H. Tanaka [Japon] ; R. Sherrington ; K. Sanpei [Japon] ; Y. Liang ; M. Saito [Japon] ; T. Tsuda ; H. Takano [Japon] ; M. Ikeda ; C. Lin ; H. Chi ; J. L. Kennedy [Canada] ; A. E. Lang [Canada] ; J. R. Wherrett [Canada] ; M. Segawa ; Y. Nomura ; T. Yuasa [Japon] ; J. Weissenbach [France] ; M. Yoshida ; M. Nishizawa ; K. K. Kidd [États-Unis] ; S. Tsuji [Japon] ; P. H. St George-Hyslop [Canada] | Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease |
004085 |
A. E. Lang [Canada] ; P. Sandor ; J. Duff [Canada] | Remoxipride in Parkinson's disease : differential response in patients with dyskinesias fluctuations versus psychosis |
004096 |
A. M. Lozano [Canada] ; A. E. Lang ; N. Galvez-Jimenez ; J. Miyasaki ; J. Duff ; W. D. Hutchinson ; J. O. Dostrovsky | Effect of GPi pallidotomy on motor function in Parkinson's disease |
004193 |
A. E. Lang [Canada] | Withdrawal akathisia: Case reports and a proposed classification of chronic akathisia |
004304 |
W. D. Hutchison [Canada] ; A. M. Lozano ; K. D. Davis [Canada] ; J. A. Saint-Cyr ; A. E. Lang ; J. O. Dostrovsky | Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients |
004444 |
J. A. Saint-Cyr [Canada] ; A. E. Taylor [Canada] ; A. E. Lang | Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease |
004633 |
R. Chen [Canada] ; P. Ashby ; A. E. Lang | Stimulus-sensitive myoclonus in akinetic-rigid syndromes |
004658 |
S. G. Adams [Canada] ; A. E. Lang | Can the Lombard effect be used to improve low voice intensity in Parkinson's disease? |
004935 |
Donaldb. Shandling [Canada] ; P. L. Carlen [Canada] ; A. E. Lang [Canada] | Parkinsonism in alcohol withdrawal: A follow‐up study |
004B81 |
J. A. Saint-Cyr [Canada] ; Ann E. Taylor [Canada] ; A. E. Lang [Canada] | PROCEDURAL LEARNING AND NEOSTYRIAL DYSFUNCTION IN MAN |
004E26 |
N. P. Quinn [États-Unis, Canada] ; A. E. Lang [États-Unis, Canada] ; W. C. Koller [États-Unis, Canada] ; C. D. Marsden [États-Unis, Canada] | PAINFUL PARKINSON'S DISEASE |
004E34 |
Ann E. Taylor [Canada] ; J. A. Saint-Cyr [Canada] ; A. E. Lang [Canada] | FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE |
005123 |
A. E. Lang [Royaume-Uni, Canada] ; N. Quinn [Royaume-Uni] ; S. Brincat [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; C. D. Parkes [Royaume-Uni] | Pergolide in late‐stage Parkinson disease |
005141 |
A. E. Lang [Royaume-Uni, Canada] ; A. E. Marsden [Royaume-Uni] ; J. A. Obeso [Royaume-Uni] ; J. D. Parkes [Royaume-Uni] | Alcohol and Parkinson disease |